ESF1积极调节MDM2并促进瘤发生
Pei Zhang1, Changning Sun2, Tiantian Yin1
1Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China; Laboratory for Marine Drugs and Biological Products, Laoshan Laboratory, Qingdao, China.
International journal of biological macromolecules
|July 6, 2024
概括
十八个S rRNA因子1 (ESF1) 通过稳定MDM2并防止p53激活来促进瘤进展. 增加ESF1表达与多种癌症 (包括胰腺癌) 的生存率差相关.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 十八个S rRNA因子1 (ESF1) 是一个核蛋白质,对胚胎发生至关重要.
- 之前的研究表明,Esf1作为瘤抑制剂p53.3的负调节剂.
- 在瘤发生过程中ESF1的作用在很大程度上仍未被探索.
研究的目的:
- 研究ESF1在癌症发展和进展中的作用.
- 阐明ESF1影响MDM2-p53通路的分子机制.
主要方法:
- 在人类瘤中分析ESF1表达和与患者存活率的相关性.
- 评估ESF1对细胞增殖,迁移和细胞亡的影响.
- 研究ESF1与MDM2的相互作用及其对MDM2无处不在和p53稳定性的影响.
主要成果:
- 增加ESF1表达与各种癌症的生存率降低有关,尤其是胰腺癌.
- ESF1调节细胞增殖,迁移,DNA损伤诱导的亡,以及整体瘤发生.
- ESF1与MDM2物理相互作用,抑制MDM2的无处不在,并增强其稳定性.
- 在癌细胞中,ESF1抑制了压力诱导的p53稳定.
结论:
- ESF1是MDM2-p53通路的重要调节者.
- 通过与MDM2的相互作用和p53.3的调制,ESF1促进瘤的进展.
- 在癌症治疗中,ESF1是潜在的治疗点.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K


